Stay updated on Lanadelumab Long-Term Safety & Efficacy in Angioedema Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab Long-Term Safety & Efficacy in Angioedema Clinical Trial page.

Latest updates to the Lanadelumab Long-Term Safety & Efficacy in Angioedema Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedA new revision entry v3.5.2 was added and an older revision v3.5.0 was removed from the record history.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check36 days agoChange DetectedRevision: v3.5.0 added; Revision: v3.4.3 removed. This reflects updates to the page's revision history display rather than trial data.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision v3.4.3 was added and Revision v3.4.2 was removed from the history.SummaryDifference0.1%

- Check72 days agoChange DetectedA new version entry 'Revision: v3.4.2' was added to the Study Record Versions. Notices about government funding lapse and the older 'Revision: v3.4.1' were removed.SummaryDifference0.7%

- Check79 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and that the NIH Clinical Center is open, and updated the history page version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check86 days agoChange DetectedUI changes include a new 'Show glossary' toggle, color-coded highlights for additions (green) and deletions (red), and an updated revision label (v3.4.0) with a 'No FEAR Act Data' note, which are presentation changes and do not modify the underlying study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

Stay in the know with updates to Lanadelumab Long-Term Safety & Efficacy in Angioedema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab Long-Term Safety & Efficacy in Angioedema Clinical Trial page.